Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and...
13 insider purchases on record · latest filing 2020-03-12.
Insiders have also filed 122 sale transactions at PTGX.